# Resolution of Discoid Lupus Alopecia With Systemic Hydroxychloroquine and Topical Pimecrolimus Combination Therapy

## TL;DR

A 46-year-old woman with discoid lupus alopecia showed improvement using a combination of hydroxychloroquine and pimecrolimus, offering new treatment insights.

## Contribution

This case demonstrates the effectiveness of combining systemic hydroxychloroquine and topical pimecrolimus for treating discoid lupus alopecia.

## Key findings

- Combination therapy significantly improved scalp lesions in a patient with treatment-resistant discoid lupus alopecia.
- Prior treatments like corticosteroids and calcineurin inhibitors showed limited success.
- The case suggests combination therapy may be a promising treatment strategy for localized DLE alopecia.

## Abstract

Discoid lupus erythematosus (DLE) is an autoimmune skin condition that is typically part of the cutaneous manifestation of systemic lupus erythematosus (SLE). DLE is characterized by erythematous patches that can progress to depigmentation and alopecia, leading to scarring and permanent hair loss if left untreated. Herein, we present a unique case of localized DLE on the scalp in a 46-year-old female with no prior history of autoimmune disorders. The patient underwent several medication trials, including intralesional corticosteroids, topical calcineurin inhibitors, topical corticosteroids, and systemic hydroxychloroquine, with limited success in treating her discoid alopecia. Subsequently, a combination therapy of oral hydroxychloroquine and topical pimecrolimus significantly improved her scalp lesion. This case highlights the efficacy of combination therapy in managing localized DLE, providing valuable insights for future research focused on DLE alopecia management and optimizing treatment strategies for similar cases.